News|Articles|July 1, 2003

Pharmaceutical marketing practices and generic drugs in the spotlight

Author(s)Jill Wechsler

Formulary committees, pharmacy benefit managers (PBMs), pharmacists, and physicians face increased scrutiny of their relationships with pharmaceutical manufacturers under a final fraud policy statement from the Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS).

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.


Latest CME